CD19 CAR T-cell Escape in Large B-cell Lymphoma: Antigen Density Matters after All.

Authors

Eric Perkey, Justin Kline

Published in

Blood cancer discovery. Pages OF1-OF4. Oct 12, 2026. Epub Oct 12, 2026.

Abstract

In this issue of Blood Cancer Discovery, Corona, Gillmor, and colleagues show that quantitative CD19 density measured before chimeric antigen receptor (CAR) T-cell infusion stratifies progression-free survival in large B-cell lymphoma, yet low antigen density rarely reflects a genetic lesion at the CD19 locus itself, suggesting that other mechanisms of CD19 downregulation may promote CAR T-cell escape. Moreover, Newsam and colleagues offer one explanation-recurrent del(3p21.31)/RHOA loss that results in decreased CD19 in trans and impairs CAR T-cell efficacy. See related article by Corona, Gillmor, and colleagues, p. XX . See related article by Newsam and colleagues, p. XX .

PMID:
42862024
Bibliographic data and abstract were imported from PubMed on 12 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.